Stay updated with breaking news from Phase 2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mission Therapeutics, a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to proceed with a phase 2 trial for its kidney treatment MTX652.
Mission Therapeutics, a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to proceed with a phase 2 trial for its kidney treatment MTX652.
The accolade stands as a testament to his significant impact and leadership within the industry.
One crucial omission in the notification is the absence of guidelines on identifying pending registered documents, says Maharashtra Societies Welfare Association.
The next stage of construction at the Greenville Spartanburg International Airport, in South Carolina, is underway.